Comparative Analysis of Regulatory Pathways in Regenerative Medicine: A Benchmark Study of Japan’s Act on the Safety of Regenerative Medicine (ASRM) against Eight Asia-Pacific Jurisdictions

Cytotherapy · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles